Related Experiment Videos

Response to increasing doses of octreotide in a patient with carcinoid syndrome

J A Ajani, J R Chesnut

European Journal of Cancer (Oxford, England : 1990)

|January 1, 1993

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Nivolumab plus chemotherapy as first-line treatment for advanced gastric, gastroesophageal junction, and esophageal adenocarcinoma: 5-year follow-up results from CheckMate 649.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Consensus guidance for prevention and management of nausea and vomiting in patients treated with zolbetuximab + chemotherapy: a RAND/UCLA modified Delphi panel study.

ESMO gastrointestinal oncology·2026

Disease-free survival as surrogate for overall survival in real-world settings for esophageal cancer: an analysis of SEER-Medicare data.

ESMO open·2024

Health-related quality of life in patients with CLDN18.2-positive, locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma: results from the SPOTLIGHT and GLOW clinical trials.

ESMO open·2024

Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma.

The British journal of surgery·2021

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience.

Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus·2019

See all related articles